Skip to main content

Table 3 Baseline laboratory characteristics of the two groups (mean ± SD)

From: Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon

  CSFP group (n = 64) Control group (n = 50) P value
WBC(109/L) 6.8 ± 1.6 6.2 ± 1.5 0.56
RDW(%) 13.2 ± 0.8 12.7 ± 0.6 0.37
MPV(fl) 10.5 ± 1.1 10.3 ± 0.8 0.04
PDW(%) 11.2 ± 1.1 10.7 ± 0.8 0.45
HDL-C(mmol/l)(mmol/l) 1.0 ± 0.4 1.1 ± 0.6 0.46
LDL-C(mmol/l) 2.5 ± 0.8 2.8 ± 0.7 0.20
TG(mmol/l) 1.4 ± 1.0 1.3 ± 0.9 0.67
TC(mmol/l) 4.3 ± 0.7 4.5 ± 0.9 0.22
FG (mmol/L) 5.4 ± 0.8 5.7 ± 0.7 0.18
Creatinine(mg/dl) 57.7 ± 11.2 55.5 ± 13.9 0.29
Cys-C(mg/l) 1.0 ± 0.3 0.9 ± 0.1 0.31
UA(umol/l) 309.5 ± 72.5 301.2 ± 62.5 0.64
GGT(U/l) 33.0 ± 28.5 35.0 ± 32.2 0.82
ALP(U/l) 70.5 ± 17.1 61.9 ± 16.1 0.007
  1. RDW red cell distribution width, MPV mean platelet volume, PDW platelet distribution width, HDL high-density lipoprotein, LDL low-density lipoprotein, TG Triglyceride, TC total cholesterol, FG fasting glucose, Cys-C Cystatin C, UA uric acid, GGT gamma glutamyl transpeptidase, ALP alkaline phosphatase
  2. Bold values are statistically significant (p < 0.05)